Evidence map›Paper›PMID 37460547›Full record

ArticleNature communications2023

Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma.

Xiao Chen, Yinglu Li, Fang Zhu, Xinjing Xu, Brian Estrella, Manuel A Pazos, John T McGuire, Dimitris Karagiannis, Varun Sahu, Mustafo Mustafokulov and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Xiao Chen *Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.ORCID 0000-0001-5059-8846
Yinglu Li *Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Fang ZhuDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Xinjing XuDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Brian EstrellaDivision of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Manuel A PazosDivision of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
John T McGuireDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Dimitris KaragiannisDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Varun SahuDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Mustafo MustafokulovDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Claudio ScuoppoInstitute for Cancer Genetics, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Francisco J Sánchez-RiveraDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.ORCID 0000-0002-8466-8563
Yadira M Soto-FelicianoDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.ORCID 0000-0002-8523-7917
Laura PasqualucciInstitute for Cancer Genetics, Columbia University Irving Medical Center, New York, NY, 10032, USA.ORCID 0000-0001-6819-7370
Alberto CicciaDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA.ORCID 0000-0003-4789-6564
Jennifer E AmengualDivision of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.ORCID 0000-0003-4117-2469
Chao LuDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, 10032, USA. cl3684@cumc.columbia.edu.ORCID 0000-0003-0982-8122
Columbia University Irving Medical Center · USMassachusetts Institute of Technology · USShandong University · CN

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Replication fork remodeling and genomic stabilityR01CA197774 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alberto Ciccia · 2016 to 2026
$4.2M
Role of MLL2 Gene Inactivation in B cell Non Hodgkin LymphomaR01CA172492 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASQUALUCCI, LAURA · 2013 to 2022
$3.6M
Epigenetic Regulation of Head and Neck Cancer Immune EvasionR01DE031873 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Chao Lu · 2022 to 2026
$2.3M
Regulation and Function of Histone H3K36 Methylation in Mammalian ChromatinR35GM138181 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LU, CHAO · 2020 to 2024
$2.0M
Understanding mechanisms of transcriptional regulation by chromatin adaptor proteinsR00GM140265 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SOTO-FELICIANO, YADIRA M · 2022 to 2024
$747k
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA172492NCI NIH HHS R01 CA197774NIDCR NIH HHS R01 DE031873NIGMS NIH HHS R00 GM140265NIGMS NIH HHS R35 GM138181
6 · The paper itself

Abstract

Interplay between chromatin-associated complexes and modifications critically contribute to the partitioning of epigenome into stable and functionally distinct domains. Yet there is a lack of systematic identification of chromatin crosstalk mechanisms, limiting our understanding of the dynamic transition between chromatin states during development and disease. Here we perform co-dependency mapping of genes using CRISPR-Cas9-mediated fitness screens in pan-cancer cell lines to quantify gene-gene functional relationships. We identify 145 co-dependency modules and further define the molecular context underlying the essentiality of these modules by incorporating mutational, epigenome, gene expression and drug sensitivity profiles of cell lines. These analyses assign new protein complex composition and function, and predict new functional interactions, including an unexpected co-dependency between two transcriptionally counteracting chromatin complexes - polycomb repressive complex 2 (PRC2) and MLL-MEN1 complex. We show that PRC2-mediated H3K27 tri-methylation regulates the genome-wide distribution of MLL1 and MEN1. In lymphoma cells with EZH2 gain-of-function mutations, the re-localization of MLL-MEN1 complex drives oncogenic gene expression and results in a hypersensitivity to pharmacologic inhibition of MEN1. Together, our findings provide a resource for discovery of trans-regulatory interactions as mechanisms of chromatin regulation and potential targets of synthetic lethality.

Indexed as

LymphomaNeoplasmsChromatinHistonesHumansPolycomb Repressive Complex 2ChromatinHistonesPolycomb Repressive Complex 2

Identifiers

PMID37460547
PMCPMC10352330
OpenAlexW4384485934

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.